-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Japanese media reported that Japan's Shun paradise university and other teams in this month's
3
issue of the American journal science published research results, found a way to investigate the concentration of caffeine in the blood to diagnose the neurological disease Parkinson's disease.According to the analysis, caffeine has the role of protecting nerve cells in the brain, the patient's small intestine to coffee and other caffeine-containing diet absorption capacity is weak, so the blood concentration is low, so there is nerve damage, resulting in Parkinson's disease." if caffeine can be absorbed from the skin to increase caffeine levels in the blood, it may prevent the onset or delay the progression of the disease, " said
, a professor at Shun paradise University who was part of the team.
”The team noted that caffeine, such as coffee, had a preventive effect on the incidence of Parkinson's disease, so they collected the blood of
108,
patients and
31,
healthy people to compare caffeine concentrations. The results showed that even though the amount of caffeine consumed was almost the same, the blood concentration in patients was only one-third that of healthy people.is a disease in which specific nerve cells in the brain are reduced and symptoms such as tremors in the hands and feet occur. It is usually diagnosed by symptoms and images, but it is difficult to judge at the beginning of the disease. If it can be diagnosed by blood in the early stages of the disease, it makes the examination method simple and helps to start treatment as soon as possible.said Parkinson's disease begins to decrease in specific nerves before it becomes ill, and the team will strive to develop a way to screen potential patients through blood tests, as well as patches that absorb caffeine from the skin.